The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Targeting Notch signalling pathway of cancer stem cells
Open accessAbstract
Cancer stem cells (CSCs) have been defined as cells within tumor that possess the capacity to self-renew and to cause the heterogeneous lineages of cancer cells that comprise the tumor. CSCs have been increasingly identified in blood cancer, prostate, ovarian, lung, melanoma, pancreatic, colon, brain and many more malignancies. CSCs have slow growth rate and are resistant to chemotherapy and radiotherapy that lead to the failure of traditional current therapy. Eradicating the CSCs and recurrence, is promising aspect for the cure of cancer. The CSCs like any other stem cells activate the signal transduction pathways that involve the development and tissue homeostasis, which include Notch signaling pathway. The new treatment targets these pathway that control stem-cell replication, survival and differentiation that are under development. Notch inhibitors either single or in combination with chemotherapy drugs have been developed to treat cancer and its recurrence. This approach of targeting signaling pathway of CSCs represents a promising future direction for the therapeutic strategy to cure cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Chieh Lin, H., Yancopoulos, G. D., & Thurston, G. (2006) · Nature · doi:10.1038/nature05355 · Cited by 1,032
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
Taichman, R. S., Cooper, C. R., Keller, E. T., Pienta, K. J., Taichman, N. S., & McCauley, L. K. (2002) · PubMed · Cited by 994
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
Ridgway, J., Zhang, G., Wu, Y., Stawicki, S., Liang, W.-C., Chanthery, Y., Kowalski, J., Watts, R. J., Callahan, C., Kasman, I., et al. (2006) · Nature · doi:10.1038/nature05313 · Cited by 986
Angiogenesis: A Team Effort Coordinated by Notch
Phng, L.-K., & Gerhardt, H. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.015 · Cited by 832
Therapeutic antibody targeting of individual Notch receptors
Wu, Y., Cain-Hom, C., Choy, L., Hagenbeek, T. J., de Leon, G. P., Chen, Y., Finkle, D., Venook, R., Wu, X., Ridgway, J., et al. (2010) · Nature · doi:10.1038/nature08878 · Cited by 720
Varnum-Finney, B., Xu, L., Brashem-Stein, C., Nourigat, C., Flowers, D., Bakkour, S., Pear, W. S., & Bernstein, I. D. (2000) · Nature Medicine · doi:10.1038/81390 · Cited by 643
Dosage‐sensitive requirement for mouse Dll4 in artery development
Duarte, A., Hirashima, M., Benedito, R., Trindade, A., Diniz, P., Bekman, E., Costa, L., Henrique, D., & Rossant, J. (2004) · Genes & Development · doi:10.1101/gad.1239004 · Cited by 563
An overview of cancer multidrug resistance: a still unsolved problem
Lage, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8111-5 · Cited by 408
Rational targeting of Notch signaling in cancer
Rizzo, P., Osipo, C., Foreman, K., Golde, T., Osborne, B., & Miele, L. (2008) · Oncogene · doi:10.1038/onc.2008.226 · Cited by 395
Patel, N. S., Li, J.-L., Generali, D., Poulsom, R., Cranston, D. W., & Harris, A. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1208 · Cited by 349
Krop, I., Demuth, T., Guthrie, T., Wen, P. Y., Mason, W. P., Chinnaiyan, P., Butowski, N., Groves, M. D., Kesari, S., Freedman, S. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.1540 · Cited by 318
The Notch signaling pathway as a mediator of tumor survival
Capaccione, K. M., & Pine, S. R. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt127 · Cited by 296
Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
Schott, A. F., Landis, M. D., Dontu, G., Griffith, K. A., Layman, R. M., Krop, I., Paskett, L. A., Wong, H., Dobrolecki, L. E., Lewis, M. T., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3326 · Cited by 277
Tolcher, A. W., Messersmith, W. A., Mikulski, S. M., Papadopoulos, K. P., Kwak, E. L., Gibbon, D. G., Patnaik, A., Falchook, G. S., Dasari, A., Shapiro, G. I., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.8282 · Cited by 268
Notch3 Gene Amplification in Ovarian Cancer
Park, J. T., Li, M., Nakayama, K., Mao, T.-L., Davidson, B., Zhang, Z., Kurman, R. J., Eberhart, C. G., Shih, I.-M., & Wang, T.-L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3610 · Cited by 259
Therapies targeting cancer stem cells: Current trends and future challenges
Dragu, D. L. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i9.1185 · Cited by 257
Yen, W.-C., Fischer, M. M., Axelrod, F., Bond, C., Cain, J., Cancilla, B., Henner, W. R., Meisner, R., Sato, A., Shah, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2808 · Cited by 246
Messersmith, W. A., Shapiro, G. I., Cleary, J. M., Jimeno, A., Dasari, A., Huang, B., Shaik, M. N., Cesari, R., Zheng, X., Reynolds, J. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0607 · Cited by 218
Curry, C. L., Reed, L. L., Golde, T. E., Miele, L., Nickoloff, B. J., & Foreman, K. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208783 · Cited by 212
Wei, P., Walls, M., Qiu, M., Ding, R., Denlinger, R. H., Wong, A., Tsaparikos, K., Jani, J. P., Hosea, N., Sands, M., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0034 · Cited by 195
Notch Inhibition as a Promising New Approach to Cancer Therapy
Purow, B. W. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_23 · Cited by 158
Notch Signaling Pathway and Cancer Metastasis
Hu, Y., Zheng, M., Zhang, R., Liang, Y., & Han, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_14 · Cited by 154
Chiorean, E. G., LoRusso, P. M., Strother, R. M., Diamond, J. R., Younger, A., Messersmith, W. A., Adriaens, L., Liu, L., Kao, R., DiCioccio, A. T., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2797 · Cited by 152
A phase II study of RO4929097 in metastatic colorectal cancer
Strosberg, J., Yeatman, T. J., Weber, J., Coppola, D., Schell, M. J., Han, G., Almhanna, K., Kim, R. D., Valone, T., Jump, H., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.056 · Cited by 148
Yabuuchi, S., Pai, S. G., Campbell, N. R., de Wilde, R. F., Oliveira, E. D., Korangath, P. C., Streppel, M. M., Rasheed, Z. A., Hidalgo, M. M., Maitra, A., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.054 · Cited by 140
Zou, J., Peng, L., Lu, F., Liu, N., Dai, J., Ye, J., Qu, X., Sun, X., Ma, D., Park, J., et al. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-3 · Cited by 117
Jesus‐Acosta, A. D., Laheru, D. A., Maitra, A., Arcaroli, J. J., Rudek, M. A., Dasari, A. N., Blatchford, P. J., Quackenbush, K. S., & Messersmith, W. A. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0083-8 · Cited by 111
Locatelli, M., Aftimos, P. G., Dees, E. C., LoRusso, P. M., Pegram, M. D., Awada, A. H., Huang, B., Cesari, R., Jiang, Y., Shaik, M. N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13727 · Cited by 93
Metastatic cancer stem cells: from the concept to therapeutics.
Liao, W., Ye, Y., Deng, Y., Bian, X., & Ding, Y.-Q. (2014) · Europe PMC (PubMed Central) · Cited by 92
Phase 2 study of RO 4929097, a gamma‐secretase inhibitor, in metastatic melanoma: SWOG 0933
Lee, S. M., Moon, J., Redman, B. G., Chidiac, T. A., Flaherty, L. E., Zha, Y., Othus, M. K. D., Ribas, A., Sondak, V. K., Gajewski, T. F., et al. (2014) · Cancer · doi:10.1002/cncr.29055 · Cited by 91
The Gamma Secretase Inhibitor MRK-003 Attenuates Pancreatic Cancer Growth in Preclinical Models
Mizuma, M., Rasheed, Z. A., Yabuuchi, S., Omura, N., Campbell, N. R., de Wilde, R. F., Oliveira, E. D., Zhang, Q., Puig, Ó., Matsui, W. H., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0017 · Cited by 91
Blockade of Dll4 Inhibits Tumour Growth by Promoting Non‐Productive Angiogenesis
Noguera‐Troise, I., Daly, C., Papadopoulos, N. J., et al. (2007) · Novartis Foundation symposium · doi:10.1002/9780470319413.ch9 · Cited by 86
Richter, S., Bedard, P. L., Chen, E. X., Clarke, B. A., Tran, B., Hotte, S. J., Stathis, A., Hirte, H. W., Razak, A. R. A., Reedijk, M., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-9965-4 · Cited by 80
The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
Huynh, C., Poliseno, L., Segura, M. F., Medicherla, R. C., Haimovic, A., Menéndez, S., Shang, S., Pavlick, A. C., Shao, Y., Darvishian, F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025264 · Cited by 76
Sahebjam, S., Bedard, P. L., Castonguay, V., Chen, Z., Reedijk, M., Liu, G., Cohen, B. L., Zhang, W.-J., Clarke, B. A., Zhang, T., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.380 · Cited by 75
Doucas, H., Mann, C. D., Sutton, C. D., Garcea, G., Neal, C. P., Berry, D. P., & Manson, M. M. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20894 · Cited by 72
Cancer Stem Cells and Tumor Response to Therapy: Current Problems and Future Prospects
Milas, L., & Hittelman, W. N. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.11.004 · Cited by 70
Mao, L., Zhao, Z., Yu, G., Wu, L., Deng, W., Li, Y., Liu, J., Bu, L., Liu, B., Kulkarni, A. B., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31115 · Cited by 70
Zhang, C. C., Pavlíček, A., Zhang, Q., Lira, M. E., Painter, C. L., Yan, Z., Zheng, X., Lee, N. V., Ozeck, M., Qiu, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1379 · Cited by 67
The Notch Pathway: Modulation of Cell Fate Decisions in Hematopoiesis
Ohishi, K., Varnum‐Finney, B., & Bernstein, I. D. (2002) · International Journal of Hematology · doi:10.1007/bf02982106 · Cited by 64
Delta-Like Ligand 4–Notch Blockade and Tumor Radiation Response
Liu, S. K., Bham, S. A. S., Fokas, E., Beech, J. S., Im, J. H., Cho, S., Harris, A. L., & Muschel, R. J. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr419 · Cited by 60
Chu, Q., Orr, B. A., Semenkow, S., Bar, E. E., & Eberhart, C. G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2119 · Cited by 59
Díaz-Padilla, I., Hirte, H. W., Oza, A. M., Clarke, B. A., Cohen, B. L., Reedjik, M., Zhang, T., Kamel‐Reid, S., Ivy, S. P., Hotte, S. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-0001-5 · Cited by 58
Hoffman, L. M., Fouladi, M., Olson, J. M., Daryani, V. M., Stewart, C. F., Wetmore, C., Koçak, M., Onar‐Thomas, A., Wagner, L. M., Gururangan, S., et al. (2015) · Child s Nervous System · doi:10.1007/s00381-015-2725-3 · Cited by 52
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma
Pan, E., Supko, J. G., Kaley, T. J., Butowski, N. A., Cloughesy, T. F., Jung, J., Desideri, S., Grossman, S. A., Ye, X., & Park, D. M. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2263-1 · Cited by 52
Therapeutic promise and challenges of targeting DLL4/NOTCH1
Yan, M. (2011) · Vascular Cell · doi:10.1186/2045-824x-3-17 · Cited by 38
Combining Notch inhibition with current therapies for breast cancer treatment
Brennan, K. R., & Clarke, R. B. (2012) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834012457437 · Cited by 24
Deenen, M. J., Klümpen, H., Richel, D. J., Sparidans, R. W., Weterman, M. J., Beijnen, J. H., Schellens, J. H. M., & Wilmink, J. W. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9723-4 · Cited by 23
Jimeno, A., LoRusso, P., Strother, R. M., Diamond, J. R., Plato, L., Younger, A., Messersmith, W. A., Kittaneh, M., Sawyer, D., Adriaens, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2502 · Cited by 15
Cited by
Clara, J. A., Monge, C., Yang, Y., & Takebe, N. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0293-2 · Cited by 752
Non-genetic mechanisms of therapeutic resistance in cancer
Marine, J.-C., Dawson, S.-J., & Dawson, M. A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-00302-4 · Cited by 635
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
Wei, X., Chen, Y., Jiang, X., Peng, M., Liu, Y., Mo, Y., Ren, D., Hua, Y., Yu, B., Zhou, Y., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01288-1 · Cited by 463
Breast Cancer Metastasis: Mechanisms and Therapeutic Implications
Park, M., Kim, D., Ko, S., Kim, A., Mo, K., & Yoon, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126806 · Cited by 406
Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
Khan, A., Ahmed, E., Elareer, N., Junejo, K., Steinhoff, M., & Uddin, S. (2019) · Cells · doi:10.3390/cells8080840 · Cited by 297
Metadata
- Authors
- Venkatesh, V., Nataraj, R., Thangaraj, G. S., Karthikeyan, M., Gnanasekaran, A., Kaginelli, S. B., Kuppanna, G., Kallappa, C. G., & Basalingappa, K. M.
- Venue
- Stem Cell Investigation
- Publisher
- AME Publishing Company
- Published
- 2018-03
- Volume
- 5
- Pages
- 5-5
- ISSN
- 2306-9759 (ISSN-L)
- 2313-0792
- OpenAlex
- W2791581335
- Cited by
- 275
- References
- 54
- FWCI
- 11.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.